Renal angiomyolipoma. A report of 11 cases.

Abstract:

:Renal angiomyolipomas are benign mesenchymal tumours. Whether isolated or associated with phacomatosis, they are histologically identical, but it is often difficult to distinguish an isolated angiomyolipoma from renal cancer. When it is combined with phacomatosis, it is frequently bilateral and can provoke retroperitoneal haemorrhages. These peculiarities qualify the therapeutical management which would a priori be conservative in the case of a benign tumour.

journal_name

Eur Urol

journal_title

European urology

authors

Mazeman E,Wemeau L,Biserte J,Riquet D

subject

Has Abstract

pub_date

1980-01-01 00:00:00

pages

328-34

issue

6

eissn

0302-2838

issn

1873-7560

journal_volume

6

pub_type

杂志文章
  • Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.

    abstract:CONTEXT:The use of neoadjuvant and adjuvant chemotherapy in the treatment of muscle-invasive bladder cancer is still controversial. OBJECTIVE:To determine the optimal use of chemotherapy in the neoadjuvant and adjuvant settings in patients with advanced urothelial cell carcinoma. Bladder preservation is also discussed...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2008.10.016

    authors: Calabrò F,Sternberg CN

    更新日期:2009-02-01 00:00:00

  • Perioperative blood transfusion does not affect survival after operation for renal cell cancer.

    abstract::We retrospectively studied the effect of perioperative blood transfusion in 208 transfused and 50 nontransfused patients operated on during a 12-year period for renal cell cancer. The 5-year renal cell cancer specific survival rate was 0.46 in the transfused patients versus 0.62 in the nontransfused patients. However,...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000475365

    authors: Jakobsen EB,Eickhoff JH,Andersen JP,Ottesen M

    更新日期:1994-01-01 00:00:00

  • The alteration of urine composition due to stone material present in the urinary tract.

    abstract:OBJECTIVES:Based on a recently introduced mathematical model approach we show that uroliths located in the urinary tract (UT) can substantially deplete the urinary concentrations of lithogenic constituents by continuous growth. METHODS:To illustrate the influence of the urinary depletion effect on urinalysis, a "typic...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/s0302-2838(03)00365-8

    authors: Laube N,Pullmann M,Hergarten S,Schmidt M,Hesse A

    更新日期:2003-11-01 00:00:00

  • Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis?

    abstract:OBJECTIVES:Hyaluronic acid is a protective barrier of the urothelium. A damaged glycosaminoglycan layer may increase the possibility of bacterial adherence and infection. This damage is proposed to be a causative factor in the development of interstitial cystitis, common urinary tract infections, and hemorrhagic cystit...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2007.03.020

    authors: Iavazzo C,Athanasiou S,Pitsouni E,Falagas ME

    更新日期:2007-06-01 00:00:00

  • The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.

    abstract:BACKGROUND:Standard management in the UK for high-risk stage 1 nonseminoma germ cell tumours of the testis (NSGCTT) is two cycles of adjuvant bleomycin, etoposide (360 mg/m2), and cisplatin (BE360P) chemotherapy, or surveillance. OBJECTIVE:To test whether one cycle of BE500P achieves similar recurrence rates to two cy...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2019.11.022

    authors: Cullen M,Huddart R,Joffe J,Gardiner D,Maynard L,Hutton P,Mazhar D,Shamash J,Wheater M,White J,Goubar A,Porta N,Witts S,Lewis R,Hall E,111 Trial Management Group.

    更新日期:2020-03-01 00:00:00

  • EAU guidelines on pain management.

    abstract::Pain is the most common symptom of any illness; the physician's therapeutic task is twofold: to discover and treat the cause of pain and the pain itself, whether or not the underlying cause is treatable, to provide relief and reduce the suffering caused by pain. Although we use the term of pain to define all sensation...

    journal_title:European urology

    pub_type: 指南,杂志文章,实务指引

    doi:10.1016/s0302-2838(03)00321-x

    authors: Francesca F,Bader P,Echtle D,Giunta F,Williams J,EAU.

    更新日期:2003-10-01 00:00:00

  • Prognostic factors for response to sildenafil in patients with erectile dysfunction.

    abstract:OBJECTIVE:To assess the clinical efficacy of sildenafil as treatment for erectile dysfunction (ED) the factors associated with treatment failure were investigated. METHODS:Open, prospective study including 244 patients suffering from ED who were evaluated by anamnesis, physical exploration, blood test, dynamic penile ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000049850

    authors: Martínez-Jabaloyas JM,Gil-Salom M,Villamón-Fort R,Pastor-Hernández F,Martínez-García R,García-Sisamón F

    更新日期:2001-12-01 00:00:00

  • Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up.

    abstract:BACKGROUND:Even though transurethral resection of the prostate remains the gold standard treatment for lower urinary tract symptoms (LUTS) refractory to medical therapy, photoselective vaporization of the prostate (PVP) has become a popular alternative. Early PVP studies seem encouraging, but few data exist regarding t...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2010.04.027

    authors: Bruyère F,Puichaud A,Pereira H,Faivre d'Arcier B,Rouanet A,Floc'h AP,Bodin T,Brichart N

    更新日期:2010-08-01 00:00:00

  • Antiandrogens as monotherapy for prostate cancer.

    abstract::Castration or antiandrogen monotherapies remain options for prostate cancer treatment as only marginal benefits have been demonstrated with combined androgen blockade, although it may be that certain subgroups of patient may benefit. Of the nonsteroidal antiandrogens, bicalutamide 150 mg was as effective as castration...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000052291

    authors: Schröder FH

    更新日期:1998-01-01 00:00:00

  • Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinoma.

    abstract:OBJECTIVES:To evaluate serum levels of the carboxy-terminal propeptide of type I procollagen (PICP) and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen (ICTP) as possible markers of bone metastases in patients with prostate carcinoma (PCA) patients. METHODS:Levels of PICP and ICTP were me...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474454

    authors: Hosoya Y,Arai K,Honda M,Sumi S,Yoshida K

    更新日期:1997-01-01 00:00:00

  • An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.

    abstract::Serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) were evaluated with double monoclonal radioimmunoassays. In 250 patients with prostatic cancer the normal limits were as follows: PSA 0.1-2.7 ng/ml, and PAP 1.09 +/- 0.45 ng/ml (mean +/- SD). In 91 untreated patients with non-metastatic tumour...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000472596

    authors: Siddall JK,Cooper EH,Newling DW,Robinson MR,Whelan P

    更新日期:1986-01-01 00:00:00

  • Efficacy of vardenafil in men with erectile dysfunction: a flexible-dose community practice study.

    abstract:OBJECTIVE:To determine the efficacy and tolerability of flexible dosing with vardenafil in a broad population of men with erectile dysfunction (ED). METHODS:10-week, open-label, flexible-dose study starting with vardenafil 10 mg, titrating to 5 mg or 20 mg at weeks 2 and 6 based on efficacy and tolerability, set in 78...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.eururo.2004.03.011

    authors: Potempa AJ,Ulbrich E,Bernard I,Beneke M,Vardenafil Study Group.

    更新日期:2004-07-01 00:00:00

  • Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification.

    abstract:BACKGROUND:Preoperative treatment of prostate cancer (PCa) changes morphology of residual tumors so that the Gleason score is no longer valid. OBJECTIVE:To codify morphologic features of preoperatively treated PCa and identify potential classifiers predictive of outcome. DESIGN, SETTING, AND PARTICIPANTS:We performed...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2009.10.020

    authors: Efstathiou E,Abrahams NA,Tibbs RF,Wang X,Pettaway CA,Pisters LL,Mathew PF,Do KA,Logothetis CJ,Troncoso P

    更新日期:2010-06-01 00:00:00

  • Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.

    abstract:BACKGROUND:The association between tumor complexity and postoperative complications after partial nephrectomy (PN) has not been well characterized. OBJECTIVE:We evaluated whether increasing renal tumor complexity, quantitated by nephrometry score (NS), is associated with increased complication rates following PN using...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2011.05.030

    authors: Simhan J,Smaldone MC,Tsai KJ,Canter DJ,Li T,Kutikov A,Viterbo R,Chen DY,Greenberg RE,Uzzo RG

    更新日期:2011-10-01 00:00:00

  • Impotence due to corporeal veno-occlusive dysfunction: long-term follow-up of venous surgery.

    abstract::Corporeal veno-occlusive dysfunction is an important cause of organic impotence and is characterized by increased flow rates to create and to maintain erection during artificial erection produced by intracavernous saline infusion. Sixty-seven patients with this erectile insufficiency underwent penile ligature-resectio...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474815

    authors: Wespes E,Delcour C,Preserowitz L,Herbaut AG,Struyven J,Schulman C

    更新日期:1992-01-01 00:00:00

  • Further experiences with the specific red cell adherence test (SRCA) in bladder cancer. a histological and cytological study.

    abstract::The red cell adherence test allows the disclosure of the blood group antigens incorporated on the surface of the urothelium. In the course of dedifferentiation the urothelium will lose its antigenicity. We applied this test on superfical bladder tumours (T1), carcinoma in situ and cytological specimens and observed a ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473993

    authors: Jakse G,Hofstädter F

    更新日期:1978-01-01 00:00:00

  • Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.

    abstract:BACKGROUND:Management of recurrent prostate cancer (CaP) after radiotherapy (RT) is dependent on accurate localization of the site of recurrent disease. OBJECTIVE:To describe the anatomic patterns and clinical features associated with CaP recurrence following RT identified on advanced imaging. DESIGN, SETTING, AND PA...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2016.08.055

    authors: Parker WP,Davis BJ,Park SS,Olivier KR,Choo R,Nathan MA,Lowe VJ,Welch TJ,Evans JD,Harmsen WS,Zaid HB,Sobol I,Moreira DM,Haloi R,Tollefson MK,Gettman MT,Boorjian SA,Mynderse LA,Karnes RJ,Kwon ED

    更新日期:2017-03-01 00:00:00

  • Changing concepts in the surgical management of renal cell carcinoma.

    abstract::The foundations of the generally accepted principles underlying the surgical management of renal cell carcinoma (RCC) were best annunciated in 1969 by Robson in his classic description of the radical nephrectomy [J Urol 1969;101;297]. Since then, much has changed in our understanding of the basic biology and genetics ...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2004.02.002

    authors: Lam JS,Shvarts O,Pantuck AJ

    更新日期:2004-06-01 00:00:00

  • Endoscopic correction of vesico-ureteric reflux in duplex systems.

    abstract::Between May 1984 and April 1990, 37 children with vesico-ureteric reflux (VUR) in 43 duplex systems were treated by endoscopic subureteric Teflon injection (STING). There were 32 girls and 5 boys; the duplex systems were complete in 27 refluxing units and incomplete in 16 refluxing units. All patients had high-grade r...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474275

    authors: Miyakita H,Ninan GK,Puri P

    更新日期:1993-01-01 00:00:00

  • Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument for.

    abstract::Combined androgen blockade (CAB) is becoming standard treatment for patients with newly diagnosed advanced prostate cancer. This statement is based on the outcome and long-term evaluation of patients treated in prospective randomised trials. Particularly, patients with 'good' prognostic signs at the time of diagnosis ...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000473836

    authors: Debruyne FM

    更新日期:1996-01-01 00:00:00

  • More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.

    abstract:BACKGROUND:Intradetrusor onabotulinumtoxinA (BoNT-ONA) injections have become a well-established therapy for refractory neurogenic detrusor overactivity (NDO). However, little is known about long-term outcome and patients' adherence to this treatment. OBJECTIVE:To assess long-term outcomes of intradetrusor BoNT-ONA in...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2016.03.052

    authors: Leitner L,Guggenbühl-Roy S,Knüpfer SC,Walter M,Schneider MP,Tornic J,Sammer U,Mehnert U,Kessler TM

    更新日期:2016-09-01 00:00:00

  • Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.

    abstract:BACKGROUND:Actors of the angiogenesis pathways are targets for the new promising targeted therapies already used in several malignancies. In bladder cancer, antiangiogenic molecules could also add to already existing treatment options. OBJECTIVE:To evaluate the involvement of angiogenesis pathways in bladder carcinoge...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2008.05.027

    authors: Pignot G,Bieche I,Vacher S,Güet C,Vieillefond A,Debré B,Lidereau R,Amsellem-Ouazana D

    更新日期:2009-10-01 00:00:00

  • Signet ring cell adenocarcinoma of the urachus.

    abstract::Signet ring cell adenocarcinoma of the bladder is rare. Only 16 cases are recorded in the literature, although two meet the requirements for being considered of urachal origin. We present the third case of signet cell adenocarcinoma of urachal origin. ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000472516

    authors: Alonso-Gorrea M,Mompo-Sanchis JA,Jorda-Cuevas M,Froufe A,Jiménez-Cruz JF

    更新日期:1985-01-01 00:00:00

  • Radical economic surgery and antiandrogenic therapy in management of prostatic cancer.

    abstract::The treatment of early stage prostatic cancer with retropubic radical prostatectomy, pelvic lymphadenectomy and antiandrogenic therapy is reported. Out of 22 patients operated in the past 9 years, none died because of the tumor and metastases appeared in 1 patient only. The latter showed a microscopic seminal vesicle ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473352

    authors: Giuliani L

    更新日期:1980-01-01 00:00:00

  • Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.

    abstract:BACKGROUND:Phosphodiesterase type 5 inhibitor (PDE5i) use is common for management of erectile dysfunction. Single-institution studies have reported conflicting data on the relationship between PDE5i use and biochemical recurrence of prostate cancer (BCR) after radical prostatectomy. OBJECTIVE:To evaluate the associat...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2015.12.013

    authors: Loeb S,Folkvaljon Y,Robinson D,Schlomm T,Garmo H,Stattin P

    更新日期:2016-11-01 00:00:00

  • Clinical relevance of growth factor antagonists in the treatment of benign prostatic hyperplasia.

    abstract::Changing demography and expectations about maintaining quality of life mean that an increasing number of men will require treatment for benign prostatic hyperplasia (BPH). Many growth factors have a role in the development of BPH. Consequently growth factor antagonists offer an attractive therapeutic option. In double...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:

    authors: Desgrandchamps F

    更新日期:1997-01-01 00:00:00

  • When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.

    abstract:BACKGROUND:Several guidelines have indicated that in patients with well-differentiated or moderately well-differentiated prostate cancer (PCa), a staging bone scan may be omitted. However, the guidelines recommendations have not yet been externally validated. OBJECTIVE:The aim of the study was to externally validate t...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2009.12.023

    authors: Briganti A,Passoni N,Ferrari M,Capitanio U,Suardi N,Gallina A,Da Pozzo LF,Picchio M,Di Girolamo V,Salonia A,Gianolli L,Messa C,Rigatti P,Montorsi F

    更新日期:2010-04-01 00:00:00

  • Improved technique of tubeless cutaneous ureterostomy and results of permanent urinary diversion.

    abstract::An improved technique of tubeless cutaneous ureterostomy through a single stoma was devised by modifing the traditional cutaneous ureterostomy. Using this method, urinary diversions were performed on 12 cases with malignancies: 6 had radical cystectomy and the other 6 had pelvic exenteration. Normal bilateral ureters ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000471550

    authors: Hirokawa M,Iwasaki A,Yamazaki A,Asakura S,Nozaki A,Yamagishi T

    更新日期:1989-01-01 00:00:00

  • Focal xanthogranulomatous pyelonephritis: partial nephrectomy as definitive treatment.

    abstract:OBJECTIVES:We report 11 cases of focal xanthogranulomatous pyelonephritis (FXGP), a disease that is very uncommon. The aim of the present work is to assess the effectivity of conservative treatment. MATERIAL AND METHODS:Eleven of the 82 cases of XGP (12.5%) diagnosed between 1970 and 1995 presented the focal form (FXG...

    journal_title:European urology

    pub_type: 杂志文章

    doi:

    authors: Osca JM,Peiro MJ,Rodrigo M,Martinez-Jabaloyas JM,Jimenez-Cruz JF

    更新日期:1997-01-01 00:00:00

  • Developing and validating the International Consultation on Incontinence Questionnaire bladder diary.

    abstract:BACKGROUND:Despite the common use of urinary diaries to assess lower urinary tract symptoms (LUTS), a standardised validated diary does not exist. OBJECTIVE:To develop a validated urinary diary, using the psychometric validation protocol used in previous International Consultation on Incontinence Questionnaire (ICIQ) ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2014.02.057

    authors: Bright E,Cotterill N,Drake M,Abrams P

    更新日期:2014-08-01 00:00:00